The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for ChAdOx1-S [recombinant] (AstraZeneca Pty Ltd)
Active ingredients
ChAdOx1-S [recombinant]
Sponsor
Date of review outcome
Lapse date
Type
Provisional approval
Indication
For the prevention of COVID-19
Therapeutic area
Infectious diseases